Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures

NCT00041925 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Vascular Diseases
Arterial Occlusive Diseases
Ischemia
Graft Occlusion, Vascular
Hyperplasia

Interventions

DRUG: CGT003 (E2F Duplex Decoy)

Sponsor

Anesiva, Inc.